Embody vs Gala: Cheap semaglutide vs flat-price care compared
Embody vs Gala pits a low entry price against a flat all-inclusive telehealth plan. Quick verdict: Embody is the lowest-cost, no-frills option starting at $69/month for compounded semaglutide; Gala is a higher, flat-price program with provider check-ins and a $220 promotion. Choose based on whether price or built-in clinical monitoring matters most.
Key differences at a glance: price, checks, and shipping
Directly comparing Embody vs Gala reveals three distinctive differences: starting price transparency, included clinical check-ins and monitoring, and stated shipping speed. Both offer compounded semaglutide and tirzepatide, are direct-pay telehealth platforms, and state you can cancel anytime.
1. Starting price and pricing transparency
Embody lists a clear starting price: compounded semaglutide at $69/month and compounded tirzepatide at $119/month, with that $69 semaglutide price described as cut from $299. Gala markets a flat all-inclusive price and a $220 promotion but the base dollar price was not visible in readable page text. If transparent entry cost is critical, Embody provides a visible starting figure.
Check Embody pricing and details
2. Clinical check-ins, monitoring and features
Gala advertises provider check-ins and dose monitoring included as part of its flat-price plan. Embody includes prescription and telemed visits and highlights 24/7 support access for dosing and side-effect questions but is described as having fewer premium features than higher-priced platforms. The comparison shows Gala emphasizes integrated check-ins while Embody emphasizes low cost and clinician review handled online.
3. Shipping speed and delivery commitments
Both platforms promise quick home delivery. Embody states free shipping with delivery in 1–2 days after clinician approval. Gala states free 2-day shipping. Both highlight no in-office visits and direct-to-door delivery.
Comparison table: Embody vs Gala
| Criteria | Embody | Gala |
|---|---|---|
| Starting price | $69/month semaglutide; $119/month tirzepatide | Base price not visible in readable page text; $220 promotion noted |
| Medication type | Compounded semaglutide and tirzepatide | Compounded semaglutide and tirzepatide |
| Provider check-ins | Prescription and telemed visits included; fewer premium monitoring features | Provider visit and prescription included; provider check-ins and dose monitoring advertised |
| Shipping speed | Free shipping; arrives in 1–2 days after approval | Free 2-day shipping to your door |
| Membership and cancellation | No monthly membership; cancel anytime | No monthly membership; cancel anytime |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Service model and who each suits
Embody positions itself for cost-driven patients who want a straightforward GLP-1 program without premium add-ons. The provider advertises a lean model: online clinician review, compounded medication, fast free delivery and no long-term commitment. Gala positions itself as a flat-price care option that includes provider check-ins and dose monitoring; it emphasizes an all-inclusive plan and a $220 promotion but does not display the base price clearly on the captured page text.
What both share
Both are direct-pay telehealth platforms offering compounded semaglutide and tirzepatide, include a clinician review and home delivery, and state the medications are compounded and not FDA-approved finished products. Both say no monthly membership and that you can cancel anytime.
See Gala flat-price plan and promotion
Safety and regulatory note
Both providers explicitly note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment availability is subject to a licensed clinician determining it is medically appropriate where mentioned.
Conclusion: Choose based on price transparency or built-in monitoring
Comparing Embody vs Gala shows a clear trade-off: Embody offers a visible, low starting price for compounded semaglutide and very fast shipping, while Gala advertises an all-inclusive flat-price plan with provider check-ins and a $220 promotion but does not show the base price in the captured text. Both use compounded medications and state similar cancellation and shipping promises.
Choose Embody if…
- You prioritize the lowest visible entry price: Embody lists compounded semaglutide at $69/month and tirzepatide at $119/month.
- You want fast free shipping with a 1–2 day delivery claim after approval.
- You prefer a lean, prescription-forward telehealth model without premium monitoring features.
Choose Gala if…
- You want an all-inclusive flat-price plan that advertises provider check-ins and dose monitoring as included.
- You value a published promotion and a stated free 2-day shipping commitment.